January 11, 2022

Episode #77: Semaglutide, A GLP-1 Agonist, Showing Success With Weight Loss and Type 2 Diabetes

1 hour 6 minutes

My guest this week is Caleb Greer, FNP-C of Precision Regenerative and Functional Medicine.

In this episode, Caleb and I discuss Semaglutide, a GLP-1 agonist. If you or someone you know has been struggling with weight loss or have diabetes this is the episode to listen to. We discuss the benefits and drawbacks of GLP-1 agonists as well as who is a good candidate, benefits outside of weight loss, what conditions are contraindicated and how long should you take them?

Sponsors

Thank you to drinkHRW.com and BiOptimizers.

Molecular Hydrogen addresses these foundations through its ability to help to manage reactive oxygen species (ROS), inflammation and improves metabolic balance. Ongoing research is demonstrating the many ways that molecular hydrogen can support human health. Visit drinkHRW.com/superhuman and use promo code LONGEVITY for 15% off.

BiOptimizers makes the only full-spectrum and most bioavailable Magnesium Supplement on the market called Magnesium Breakthrough – I use it every day and every night for brain benefits, to optimize my sleep, and much more. Visit www.magnesiumbreakthrough.com/bionat and use code bionat for 10% off!

EPISODE TAKEAWAYS

[05:50] When did Caleb start using GLP-1 agonists in his practice?..

[10:00] What controls appetite regulation and homeostasis?..

[18:00] What exactly is GLP-1 and what do GLP-1 agonists do?

[25:00] Will the price for these GLP-1 agonists go down anytime soon?..

[28:02] Due to slower gastric emptying, is it beneficial to use digestive enzymes while taking a GLP-1 agonist?..

[31:00] Besides the metabolic benefits, what other benefits do GLP-1 agonists offer?

[41:10] Does GLP-1 improve insulin sensitivity?..

[47:00] Does GLP-1 increase neurogenesis and neurotrophic factors?

[49:50] Can you drink too much water?..

[55:20] Hair loss with weight loss? How to increase protein intake while cutting food intake?..

[57:10] The dark side of GLP-1 agonists…